RENO, Nev., March 16, 2020 /PRNewswire/ -- Rapid Dx for Life praises the leadership of the United States government by enacting a National Emergency for Covid19 on March 13th to enhance the resources and tools by which US states can effectively screen, treat, and cure this disease. All citiz

HIGHLANDS RANCH, Colo., March 16, 2020 /PRNewswire/ -- Destination Pet today announced plans to acquire VitalPet. A formal written order approving the sale has been filed in the U.S. Bankruptcy Court in Houston. The transaction is expected to close in the coming weeks, subject to customary closing conditions.Headquartered

CARMIEL, Israel, March 16, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, announced today tha

INDIANAPOLIS, March 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to baricitinib for the treatment of alopecia areata (AA), an autoimmune disorder that can cause unpredictable hair loss on the scalp, face an

WASHINGTON, March 16, 2020 /PRNewswire/ -- Every day, kids surprise their families by getting into medicine. There are more than 47,000 children under age 6 seen in emergency rooms every year for medicine poisoning – that's 5 children every hour. A new research report from Safe Kids Worldwide reveals common misconceptions families have about how to protect children

STAINES-UPON-THAMES, United Kingdom, March 16, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today confirmed that its subsidiary, Mallinckrodt ARD LLC, received a decision from the U.S. District Court for the District of Columbia in its suit against HHS and CMS (or the Agency) regarding the co

PALO ALTO, Calif., March 16, 2020 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2019.

BENTONVILLE, Ark., March 16, 2020 /PRNewswire/ -- GLUCODOWN® Diabetic Friendly Tea Mix – manufactured by Glucose Health, Inc. (OTC: GLUC) and the first iced tea mix enriched with healthy soluble fiber – is generating impressive sales growth at Amazon. GLUCODOWN® Amazon revenues grew 224% in the latest fiscal period, 2019, vs. the previous fiscal

ATHENS, March 16, 2020 /PRNewswire/ -- Coming from a small country bouncing back from one of the deepest and most draining recessions in history, where data, analytics & coding talent is nonetheless extremely strong, Co

STOCKHOLM, March 16, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that it has entered into a license agreement with US biotech company Tango Therapeutics for one of Medivir's preclinical research programs. Under the terms of the agreement, Medivir will receive an undisclosed upfront payment and is eligible to receive multiple undis